CycloeucalenolCAS# 469-39-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 469-39-6 | SDF | Download SDF |
PubChem ID | 101690 | Appearance | Powder |
Formula | C30H50O | M.Wt | 426.7 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC1C2CCC3C4(CCC(C4(CCC35C2(C5)CCC1O)C)C(C)CCC(=C)C(C)C)C | ||
Standard InChIKey | HUNLTIZKNQDZEI-PGFZVWMDSA-N | ||
Standard InChI | InChI=1S/C30H50O/c1-19(2)20(3)8-9-21(4)23-12-14-28(7)26-11-10-24-22(5)25(31)13-15-29(24)18-30(26,29)17-16-27(23,28)6/h19,21-26,31H,3,8-18H2,1-2,4-7H3/t21-,22+,23-,24+,25+,26+,27-,28+,29-,30+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Cycloeucalenol produces mild cardiotonic effects. 2. Cycloeucalenol and its regio-isomer were present in a ratio of 1.04:1, a dose-dependent decrease in cell viability was observed . |
Cycloeucalenol Dilution Calculator
Cycloeucalenol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3436 mL | 11.7178 mL | 23.4357 mL | 46.8713 mL | 58.5892 mL |
5 mM | 0.4687 mL | 2.3436 mL | 4.6871 mL | 9.3743 mL | 11.7178 mL |
10 mM | 0.2344 mL | 1.1718 mL | 2.3436 mL | 4.6871 mL | 5.8589 mL |
50 mM | 0.0469 mL | 0.2344 mL | 0.4687 mL | 0.9374 mL | 1.1718 mL |
100 mM | 0.0234 mL | 0.1172 mL | 0.2344 mL | 0.4687 mL | 0.5859 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hamamelitannin
Catalog No.:BCC8182
CAS No.:469-32-9
- BMS-536924
Catalog No.:BCC1177
CAS No.:468740-43-4
- Cimilactone A
Catalog No.:BCN7948
CAS No.:468733-06-4
- 3-Benzofurancarboxaldehyde
Catalog No.:BCC8622
CAS No.:4687-25-6
- Dihydrocorynantheine
Catalog No.:BCN3747
CAS No.:4684-43-9
- Picrinine
Catalog No.:BCN5518
CAS No.:4684-32-6
- Norscopolamine
Catalog No.:BCN3983
CAS No.:4684-28-0
- Orphenadrine Citrate
Catalog No.:BCC4572
CAS No.:4682-36-4
- Drimenol
Catalog No.:BCN7224
CAS No.:468-68-8
- Mesembrenone
Catalog No.:BCN3753
CAS No.:468-54-2
- Lupulon
Catalog No.:BCC8204
CAS No.:468-28-0
- Colupulone
Catalog No.:BCN8097
CAS No.:468-27-9
- Jervine
Catalog No.:BCN2975
CAS No.:469-59-0
- 5'-IMPdisodium salt
Catalog No.:BCN8175
CAS No.:4691-65-0
- Carbenicillin
Catalog No.:BCC5192
CAS No.:4697-36-3
- Uncarine D
Catalog No.:BCC8262
CAS No.:4697-68-1
- Isoalantolactone
Catalog No.:BCN4955
CAS No.:470-17-7
- Cinobufagin
Catalog No.:BCN5367
CAS No.:470-37-1
- Marinobufagin
Catalog No.:BCC9238
CAS No.:470-42-8
- Stachyose tetrahydrate
Catalog No.:BCC8252
CAS No.:470-55-3
- 1-Kestose
Catalog No.:BCN8292
CAS No.:470-69-9
- Cineole
Catalog No.:BCN2686
CAS No.:470-82-6
- Benzoyl-DL-methionine
Catalog No.:BCC8863
CAS No.:4703-38-2
- Beta-Lapachone
Catalog No.:BCC5088
CAS No.:4707-32-8
Cycloeucalenol-obtusifoliol isomerase. Structural requirements for transformation or binding of substrates and inhibitors.[Pubmed:2731540]
Eur J Biochem. 1989 May 15;181(3):615-26.
The molecular features of 19 synthetic substrates and ground-state analogues of Cycloeucalenol, the natural substrate of Cycloeucalenol - obtusifoliol isomerase, a membrane-bound enzyme specific to higher plants, and of 9 synthetic carbocationic analogues of the high-energy intermediate occurring during the reaction catalyzed by the isomerase, were related to their ability to be transformed by this enzyme (catalytical competence) and their potency as inhibitors of this enzyme. With substrates and ground-state analogues it has been possible to determine at least two critical domains: significant binding requires the presence of the 3 beta-hydroxyl group on the ring A with the correct stereochemistry together with absence of a 4 beta-methyl group. Moreover initial enzyme-substrate interaction appears to be dependent upon the accessibility of the 3 beta-oxygen. Substitutions on the ring B do not preclude binding whereas they are of great influence on substrate transformation. Modifications of the ring A and other modifications suggest that ground-state and high-energy intermediate analogues bind two different conformations of the isomerase active site.
Isolation of cycloeucalenol from Boophone disticha and evaluation of its cytotoxicity.[Pubmed:24273848]
Nat Prod Commun. 2013 Sep;8(9):1213-6.
Boophone disticha (Amaryllidaceae) is widely used in traditional medicine in southern Africa. Several alkaloids, volatile oils and fatty acids have been isolated from the plant. However, there has been no literature report of a triterpene from B. disticha. Cycloeucalenol, a cycloartane triterpene, together with its regio-isomer, was isolated from the ethyl acetate extract of the bulbs using column chromatography and preparative thin layer chromatography. Structural elucidation was carried out using 1D and 2D NMR and mass spectroscopy. The MTT and neutral red assays were used to assess the cytotoxicity of the compound in human neuroblastoma (SH-SY5Y) cells. The compound was obtained as a mixture of two regio-isomers, which were separated for the first time by chromatographic optimization. Integration of the 1H NMR spectrum showed that Cycloeucalenol and its regio-isomer were present in a ratio of 1.04:1. A dose-dependent decrease in cell viability was observed using both cytotoxicity assays. IC51 values of 173.0 +/- 5.1 microM and 223.0 +/- 6.4 microM were obtained for the MTT and neutral red assays, respectively, indicative of the low toxicity of the compound. This work describes for the first time, the presence of triterpene compounds from the genus Boophone.
Study on cardiac contractility of cycloeucalenol and cycloeucalenone isolated from Tinospora crispa.[Pubmed:12413712]
J Ethnopharmacol. 2002 Nov;83(1-2):95-9.
This report describes the isolation of two triterpenes from the stems of Tinospora crispa, namely, Cycloeucalenol (1). and cycloeucalenone (2). for the first time. It was found that Cycloeucalenol (1). slightly increased the right atrial force of contraction whereas it showed an initial reduction followed by sustained reduction of about 10% on the left atria of the rat in vitro. Cycloeucalenone showed slight change from the control on the right and left atrial force. These results suggest that Cycloeucalenol and cycloeucalenone produced mild cardiotonic effects.